DPS is a global architectural engineering, consulting, and project management company, serving high-tech industries around the world. DPS designs biopharmaceutical facilities from the first generation of recombinant proteins through monoclonal antibodies (mAbs) and modern-day novel therapies, such as gene and cell therapy, viral vectors, RNA, oligonucleotides, microbiome, and exosome. Our teams also embrace technology advances, such as continuous manufacturing (perfusion and continuous downstream processing), advanced process analytical technology, improved single-use systems, and modular and podular designs.